At CD BioGlyco, we leverage decades of specialized expertise in glycobiology to provide a high-end, custom production service for seaweed oligosaccharide ingredients tailored for dry eye therapeutic and cosmeceutical development. Our service focuses on delivering highly purified, structurally defined oligosaccharide molecules, such as specific neoagarooligosaccharides (NAOs) and other derivatives, which are poised to become the next generation of effective, naturally sourced treatments for dry eye syndrome (DES).
Key Technologies
- Advanced Extraction Techniques: To maximize yield and maintain the integrity of the initial polysaccharide feedstock, we employ advanced, environmentally-friendly extraction technologies such as microwave-assisted extraction (MAE) and ultrasound-assisted extraction (UAE).
- Enzymatic Hydrolysis/Degradation: We utilize a proprietary library of highly selective and characterized glycoside hydrolases to cleave high-molecular-weight seaweed polysaccharides into target oligosaccharide fragments with defined degrees of polymerization and chemical structures. This enzymatic precision is key to ensuring consistent bioactivity.
Custom Seaweed Oligosaccharide: Enabling Next-Generation Ocular Therapeutics
The need for non-steroidal, anti-inflammatory, and highly biocompatible treatments for DES is paramount. Seaweed oligosaccharides, particularly those derived from agar, such as NAOs, have demonstrated significant potential in mitigating DES symptoms by improving tear film stability, reducing ocular surface inflammation, and promoting mucin secretion. CD BioGlyco specializes in providing a customized production service for these critical raw materials to accelerate your drug development efforts:
- Custom Oligosaccharide Synthesis: We offer the tailored production of a broad spectrum of seaweed oligosaccharides, including specific α- and β-linked NAOs, defined fucoidan oligosaccharides, and various alginate oligosaccharides, with customizable molecular weight ranges and sulfation patterns to meet the precise requirements of your dry eye model.
- Raw Material Customization for DES Models: Whether your research focuses on aqueous-deficient, evaporative, or inflammatory DES, we provide oligosaccharide raw materials optimized for specific in vitro or in vivo models. For instance, we target the production of oligosaccharides with enhanced hygroscopic properties for tear film stabilization or specific anti-inflammatory activity for chronic ocular surface disease models.
- Analytical Services and Regulatory Support: Beyond production, we provide comprehensive characterization services to support your research, including purity determination, stability testing, and contaminant analysis.
Workflow
1. Raw Material Sourcing and Pre-treatment
This initial step involves selecting the appropriate, high-quality seaweed species (e.g., Gracilaria for agar derivatives) and performing stringent pre-treatment steps. Activities include washing, drying, and coarse milling of the biomass to prepare the polysaccharide feedstock for efficient extraction, ensuring the removal of contaminants and maximizing accessibility for downstream processing.
2. Polysaccharide Extraction
The chosen extraction technology (e.g., hot water, acid/alkaline) is applied to liberate the crude high-molecular-weight polysaccharide from the pre-treated seaweed biomass. The process is carefully optimized to maximize the yield of the target polysaccharide while maintaining its chemical integrity.
3. Enzymatic Depolymerization & Hydrolysis
The purified polysaccharide is subjected to controlled enzymatic hydrolysis using highly specific, proprietary enzymes. This critical step breaks down the polymer into the desired low-molecular-weight oligosaccharide fragments, such as NAOs, with a targeted degree of polymerization that correlates with enhanced biological activity.
4. High-Resolution Purification
The hydrolysate mixture is then processed through our multi-stage purification platform. This involves techniques like ultrafiltration and various forms of chromatography to remove unreacted polymers, monosaccharides, proteins, and other impurities, ultimately yielding a highly purified oligosaccharide fraction suitable for therapeutic formulation.
5. Structural Characterization & Quality Control (QC)
Each purified batch undergoes comprehensive analytical testing. CD BioGlyco performs detailed structural analysis (NMR, MS) and purity assessments (HPLC) to confirm the identity, molecular weight, and absence of contaminants, guaranteeing the ingredient meets all pre-defined specifications and quality benchmarks.
6. Freeze-Drying and Final Packaging
The purified and QC-approved oligosaccharide solution is concentrated and then lyophilized (freeze-dried) to produce a stable, high-purity powder ingredient. The final product is packaged under controlled conditions to ensure long-term stability and is accompanied by a detailed certificate of analysis (CoA) for immediate use in client R&D or manufacturing.
Applications
- Anti-Metastasis Activity
By inhibiting the adhesion and migration of cancer cells, these glycans potentially can be used as anti-metastatic agents, limiting the spread of tumors.
- Induction of Apoptosis
Certain oligosaccharide structures have demonstrated the ability to selectively trigger apoptosis in various cancer cell lines, offering a targeted mechanism of action.
- Regulation of Inflammation
The anti-inflammatory capacity, crucial for dry eye treatment, is also applicable in systemic inflammatory conditions by regulating the activity of transcription factors like NF-κβ and mitigating excessive inflammatory responses.
- Macrophage Activation
They act as agonists for immune receptors, promoting the activation of macrophages and enhancing the secretion of beneficial cytokines like IL-2 and TNF-α, thereby boosting the host's anti-tumor or anti-viral immunity.
Advantages
- Unrivaled Specialization
With over years of experience solely focused on glycans, our deep scientific knowledge in oligosaccharide structure-activity relationships is unparalleled.
- High-Purity, Defined Ingredients
Our multi-stage purification and rigorous quality control processes guarantee an ingredient purity level essential for ophthalmic drug development.
- Scalability and Compliance
Our established production facility adheres to strict quality standards, offering seamless scalability from small R&D batches to large-scale preclinical supply.
- Comprehensive Customer Service
We are online anytime to solve your problems, from initial consultation to project progress, project delivery, after-sales service, etc.
Frequently Asked Questions
How do you ensure the high purity required for ophthalmic use?
We use multi-stage, high-resolution purification techniques, including advanced chromatography and ultrafiltration, followed by rigorous quality control using nuclear magnetic resonance (NMR) and high-performance liquid chromatography (HPLC) to guarantee purity often exceeding 95%, which is critical for minimizing irritation in ocular formulations.
Can your production process be scaled up to meet commercial drug demand?
Absolutely. Our validated production platform is designed for seamless, cost-effective scalability, ensuring you have a reliable, consistent supply from initial R&D through to commercial manufacturing volumes.
Customer Review
"The specific β-linked neoagaroligosaccharide provided by CD BioGlyco was a game-changer for our preclinical dry eye study. The unmatched purity and batch consistency allowed us to obtain highly reproducible in vitro data."
- Dr. E.V., Head of Pharmaceutical R&D
"We previously struggled with a lot of variation from a different supplier. Switching to CD BioGlyco's production service gave us the confidence to scale. Their structural characterization data was impeccable, drastically simplifying our internal Quality Control processes."
– K.S., Ophthalmic Cosmeceuticals
"The team was exceptionally responsive to our needs for a non-sulfated oligosaccharide derivative. Their ability to precisely customize the molecular weight enabled us to create a topical formulation with ideal viscosity and penetration kinetics for the ocular surface."
– S.H., Biotechnology Formulation Scientist
Associated Services
CD BioGlyco is the industry leader in the custom production of high-purity, structurally defined seaweed oligosaccharide ingredients for cutting-edge therapeutic development, with a specialized focus on dry eye treatment. Our integration of decades of glycan expertise, advanced enzymatic production, and stringent quality control ensures you receive an ingredient that is not only effective but also scalable. Please feel free to contact us to discuss a custom oligosaccharide design.
